Q2 EBITDA exceeded guidance despite sales headwinds from challenging market conditions, with strong free cash flow and significant progress on debt reduction. Full-year outlook was revised downward, but restructuring, asset sales, and new product growth are expected to drive a return to growth in 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.